Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 616 AL 630

Molecular Targets Underlying the Neuroprotective Effects of Boswellic Acid: A Systematic Review

Khaafi F, Javadi B.

Mini Rev Med Chem. 2023;23(19):1912-1925. doi: 10.2174/1389557523666230330113611.

Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer's Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil

Killick R, Elliott C, Ribe E, Broadstock M, Ballard C, Aarsland D, Williams G.

Int J Mol Sci. 2023 Jul 7;24(13):11219. doi: 10.3390/ijms241311219.

The Role of Sesamin in Targeting Neurodegenerative Disorders: A Systematic Review

Ghaderi MA, Emami SA, Beirak Olia MD, Javadi B.

Mini Rev Med Chem. 2023;23(6):756-770. doi: 10.2174/1389557522666220523112027.

A New Hope in Alzheimer's Disease Psychosis: Pimavanserin

Kurhan F, Akın M.

Curr Alzheimer Res. 2023;20(6):403-408. doi: 10.2174/1567205020666230825124922.

Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial

Fernandez HH, Weintraub D, Macklin E, Litvan I, Schwarzschild MA, Eberling J, Videnovic A, Kenney CJ; Parkinson Study Group SYNAPSE Investigators.

Parkinsonism Relat Disord. 2023 Sep;114:105511. doi: 10.1016/j.parkreldis.2023.105511. Epub 2023 Jul 13.

Wrist-worn sensor-based measurements for drug effect detection with small samples in people with Lewy Body Dementia

Chen C, Kowahl NR, Rainaldi E, Burq M, Munsie LM, Battioui C, Wang J, Biglan K, Marks WJ Jr, Kapur R.

Parkinsonism Relat Disord. 2023 Apr;109:105355. doi: 10.1016/j.parkreldis.2023.105355. Epub 2023 Mar 4.

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis

Bittner N, Funk CSM, Schmidt A, Bermpohl F, Brandl EJ, Algharably EEA, Kreutz R, Riemer TG.

Drugs Aging. 2023 Nov;40(11):953-964. doi: 10.1007/s40266-023-01065-x. Epub 2023 Sep 8.

Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer's and Parkinson's Patients

Fang C, Hernandez P, Liow K, Damiano E, Zetterberg H, Blennow K, Feng D, Chen M, Maccecchini M.

J Prev Alzheimers Dis. 2023;10(1):25-33. doi: 10.14283/jpad.2022.84.

Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis

Corniello C, Dono F, Evangelista G, Consoli S, De Angelis S, Cipollone S, Liviello D, Polito G, Melchiorre S, Russo M, Granzotto A, Anzellotti F, Onofrj M, Thomas A, Sensi SL.

Seizure. 2023 Jul;109:62-67. doi: 10.1016/j.seizure.2023.05.017. Epub 2023 May 21.

[Abnormal posture of the trunk related to donepezil hydrochloride: report of 2 cases]

Ueda A, Komatsu K, Takahashi M.

Rinsho Shinkeigaku. 2023 Feb 25;63(2):85-91. doi: 10.5692/clinicalneurol.cn-001792. Epub 2023 Jan 31.

Protocol of a randomized controlled trial investigating Deep Brain Stimulation for MOtor symptoms in patients with Parkinson's disease DEmentia (DBS-MODE)

Sisodia V, Swinnen BEKS, Dijk JM, Verwijk E, van Rooijen G, Lemstra AW, Schuurman PR, de Bie RMA.

BMC Neurol. 2023 Apr 21;23(1):160. doi: 10.1186/s12883-023-03142-5.

Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders

Birajdar SV, Mazahir F, Alam MI, Kumar A, Yadav AK.

Eur J Pharmacol. 2023 Dec 15;961:176117. doi: 10.1016/j.ejphar.2023.176117. Epub 2023 Oct 30.

Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases

Lizama BN, Kahle J, Catalano SM, Caggiano AO, Grundman M, Hamby ME.

Int J Mol Sci. 2023 Mar 26;24(7):6251. doi: 10.3390/ijms24076251.

The Regulation, Functions, and Signaling of miR-153 in Neurological Disorders, and Its Potential as a Biomarker and Therapeutic Target

Jaberi KR, Alamdari-Palangi V, Jaberi AR, Esmaeli Z, Shakeri A, Gheibi Hayat SM, Tajbakhsh A, Savardashtaki A.

Curr Mol Med. 2023;23(9):863-875. doi: 10.2174/1566524023666220817145638.

Neurobiochemical characteristics of arginine-rich peptides explain their potential therapeutic efficacy in neurodegenerative diseases

Eskandari S, Rezayof A, Asghari SM, Hashemizadeh S.

Neuropeptides. 2023 Oct;101:102356. doi: 10.1016/j.npep.2023.102356. Epub 2023 Jun 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias